Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2019-02-08, Stock:ABBV, The news for the past five days is as follows:
2019-02-01: NEWS1: Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance.NEWS2: Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance.NEWS3: Roche (RHHBY) 2018 Sales Up on Solid New Drugs Performance.NEWS4: Notable ETF Inflow Detected - XLV, AMGN, ABBV, LLY.NEWS5: Notable ETF Inflow Detected - XLV, AMGN, ABBV, LLY.NEWS6: Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY.NEWS7: Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY.NEWS8: The Zacks Analyst Blog Highlights: Union Pacific, AbbVie and General Dynamics.NEWS9: The Zacks Analyst Blog Highlights: Union Pacific, AbbVie and General Dynamics.NEWS10: The Zacks Analyst Blog Highlights: Union Pacific, AbbVie and General Dynamics.NEWS11: Pharma Stock Roundup: Q4 Earnings, Pipeline Updates at PFE, RHHBY.NEWS12: Watch These Healthcare Stocks in First Week of February.NEWS13: The 12 Best Dividend Aristocrats- Part 1.
2019-02-04: NEWS1: Health Care Sector Update for 02/04/2019: ABMD,OMCL,BLRX,ABBV,BLK.NEWS2: Health Care Sector Update for 02/04/2019: ABMD,OMCL,BLRX,ABBV,BLK.NEWS3: AbbVie Falls 3%.
2019-02-05: NEWS1: Merck CEO Frazier to testify at Senate drug pricing hearing.NEWS2: 3 Biotech Stocks That Pay Solid Dividends.NEWS3: 3 Red-Hot Stocks (And 3 That Aren’t).NEWS4: Pharma execs will testify before Congress &apos;one way or another,&apos; US senator says.NEWS5: Pharma execs will testify before Congress 'one way or another,' US senator says.NEWS6: Lilly/Incyte's Olumiant Meets Endpoint in Eczema Studies.NEWS7: Lilly/Incyte's Olumiant Meets Endpoint in Eczema Studies.NEWS8: Lilly/Incyte's Olumiant Meets Endpoint in Eczema Studies.NEWS9: Flip the Script: Drugmakers Blame Middlemen for Price Increases.NEWS10: Johnson Fistel, LLP Announces Investigations of AbbVie Inc., Macquarie Infrastructure Corporation, OPKO Health, Inc. and Uxin Limited; Investors Encouraged to Contact Firm.
2019-02-06: NEWS1: At least four pharma CEOs to testify at Senate drug pricing hearing.NEWS2: At least four pharma CEOs to testify at Senate drug pricing hearing.NEWS3: Congress invites 7 drugmakers to testify at potentially hostile hearing on drug prices. Here's what they're saying.NEWS4: Flip the Script: Drugmakers Blame Middlemen for Price Increases.NEWS5: 3 Biotech Stocks That Pay Solid Dividends.NEWS6: 3 Biotech Stocks That Pay Solid Dividends.
2019-02-07: NEWS1: Is AbbVie or Celgene Expected to Report Faster Revenue Growth?.NEWS2: What Analysts Recommend for AbbVie and Celgene This Month.NEWS3: ABBV March 29th Options Begin Trading.NEWS4: ABBV March 29th Options Begin Trading.NEWS5: Enanta Pharmaceuticals Inc (ENTA) Q1 2019 Earnings Conference Call Transcript.

Answer: Rise